Interestingly, a recent study provided strong evidence for the protective role of CCR5 antagonism during Chronic Obstructive Pulmonary Disease (COPD) exacerbations caused by influenza in which CCL3 levels but no CCL5, correlated with an exacerbated inflammatory process (46). Here, CCR5 is linked to chronic obstructive pulmonary disease.